Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Kids face higher neurodevelopmental risks from mom's depression itself, not just the meds. A large Welsh study found children of mothers with depression had elevated rates of special educational needs whether or not antidepressants were used. Researchers say the higher risk seen with antidepressant exposure likely reflects more severe underlying depression rather than a direct drug effect.
A new study published in PLoS Medicine adds important nuance to the ongoing debate about antidepressant use during pregnancy. Analyzing data from over 167,000 children born in Wales between 2009 and 2016, researchers found that maternal depression itself — not just prenatal antidepressant exposure — significantly raises the risk of special educational needs (SEN) in offspring, including conditions like autism spectrum disorder (ASD), ADHD, and learning difficulties.
Children exposed to both maternal depression and antidepressants had the highest predicted probability of SEN (26.5 per 100), but even those exposed to untreated maternal depression alone showed elevated risk (23.6 per 100) compared to unexposed children (20 per 100). Researchers caution that the higher risk associated with antidepressant use may simply be a marker of more severe depression rather than a direct drug effect.
By the Numbers:
Why it matters: This study reinforces that untreated maternal depression carries real risks for child development — and that clinicians shouldn't reflexively avoid antidepressants in pregnancy. The elevated risks seen with medication use likely reflect disease severity, not the drugs themselves, supporting a nuanced, individualized approach to treating depression during pregnancy.
